Pharma firms hopeful for year ahead
Mar 16 2012 Read 927 Times
Pharma firms around the world are broadly hopeful about revenue growth over the next 12 months, according to a new study.
Nearly half – 47 per cent – of respondents to the study by iCD Research said they were "more optimistic" about growth.
Some 28 per cent said they were "neutral" and 23 per cent said they were less optimistic.
However, ongoing economic concerns have led to firms revising down their forecasts, with global economic growth projected to be 2.5 per cent in 2012 and 3.1 per cent in 2013.
This is down from estimates of 3.6 per cent. Market turmoil in Europe and lagging growth in emerging economies are fuelling the revised forecasts, iCD said.
But emerging markets – China, India and Brazil – are set to see positive growth rates this year, spearheaded by China, which will enjoy double digit growth on the back of a successful 2011.
According to separate research by Espicom, the UK pharma market is set to experience moderate growth over the coming years.
Posted by Fiona Griffiths
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Issue... Articles - Industrial Applications of Offline and Online Comprehensive Gas Chromatography - Improving Workflow in Group-Type GC×GC Analysis of Petrochemicals - Identifi ca...
View all digital editions
Jun 03 2018 San Diego, CA, USA
Jun 11 2018 Frankfurt, Germany
Jun 19 2018 Busan, Korea
Jul 08 2018 Baltimore, MD, USA
Jul 29 2018 Washington DC, USA